Molika Ashford
Articles
-
2 weeks ago |
360dx.com | Molika Ashford
NEW YORK – Pregnancy health firm Mirvie, said this week that it is close to the launch of the first RNA-based blood test to predict pregnant individuals' risk of developing preeclampsia, a hypertensive condition that can lead to pre-term birth, after generating positive data from a study that analyzed more than 9,000 pregnancies.
-
2 weeks ago |
360dx.com | Molika Ashford
NEW YORK – Esophageal cancer testing firm Cyted Health said last week that it has begun enrollment of a new clinical validation study called DETECT-ME to build evidence and drive adoption of its molecular test for Barrett's esophagus and esophageal cancer.
-
3 weeks ago |
360dx.com | Molika Ashford
NEW YORK – Veracyte is in the midst of an effort to prove out the minimal residual disease technology adopted with its acquisition of C2i Genomics last year, and said last week that new data presented at the European Association of Urology Congress have left it confident that it will be able to launch the test for bladder cancer monitoring in the first half of 2026. The C2i approach is tumor informed, akin to tests developed by firms like Natera, Inivata (part of NeoGenomics), and others.
-
4 weeks ago |
360dx.com | Molika Ashford
NEW YORK – Swedish diagnostics firm Elypta shared promising results this week from a clinical trial of its non-invasive metabolite-based test intended to aid clinicians in monitoring kidney cancer patients for recurrence while reducing the need for costly imaging.
-
1 month ago |
360dx.com | Molika Ashford
NEW YORK – Although researchers don't expect to report final results from a UK-based randomized prospective study of Grail's blood-based multi-cancer screening test for about a year, debate over the results has already begun.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 136
- Tweets
- 31
- DMs Open
- No
Thanks @EricTopol. Important to watch how inst. like @MDAndersonNews do making case to payors. @GenomeWeb @WiredUK @drjmedeiros
RT @molquant: #PMWC16 "will cfDNA work for #earlycancerdetection?" "It's an extremely difficult problem, but could save more lives than dr…
Liquid biopsy at #PMWC16 - no conference room is large enough to handle it.
